Clik here to view.
ボストン・オンコロジーとキング・ファハド・メディカル・シティ（KFMC）が、サウジアラビアにおける細胞・遺伝子治療のローカライズ推進で提携
米マサチューセッツ州ケンブリッジ＆サウジアラビア・リヤド （ビジネスワイヤ） — サウジアラビア王国の医療を大きく変える画期的な取り組みとして、ボストン・オンコロジーとキング・ファハド・メディカル・シティ（KFMC）は、細胞・遺伝子治療のローカライズ（現地化）について提携するために基本合意書に調印しました。...
View ArticleClik here to view.
BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies...
WALTHAM, Mass. BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, announced that it will collaborate with Takeda on immuno-oncology...
View ArticleClik here to view.
BostonGeneは、AIを活用した分子プロファイリングによる免疫療法評価でTakedaとのパートナーシップを発表
WALTHAM, Mass. （ビジネスワイヤ） —...
View ArticleClik here to view.
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of...
TOKYO RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that 13 patients have been enrolled in an observational study 1 of...
View ArticleClik here to view.
Singapore’s National Precision Medicine (NPM) Programme Engages Oxford...
OXFORD, England Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore’s National Precision Medicine (NPM) programme, led by Precision Health Research,...
View ArticleClik here to view.
Huonslab Announces Issuance of Process Patent for HyDIFFUZETM Drug Delivery...
SEONGNAM, South Korea Huonslab, Co. Ltd. (“Huonslab”), a subsidiary of Huons Global (KOSDAQ: 084110) today announced the registration of process patent covering the HyDIFFUZE™, rHuPH20 manufacturing...
View ArticleClik here to view.
Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer...
SEOUL, South Korea Bruker Corporation is pleased to announce the successful installation and acceptance of a 1.2 GHz Avance® Nuclear Magnetic Resonance (NMR) spectrometer at the Korea Basic Science...
View ArticleClik here to view.
Inocras to Offer High Quality and Cost-Effective Whole Genome Sequencing and...
SAN DIEGO Inocras Inc., a leader in whole genome sequencing and bioinformatics, announced today that it is now offering whole genome sequencing services using the UG 100TM sequencer from Ultima...
View ArticleClik here to view.
ALAFIA Unveils AIVAS Interactive Supercomputer, an All-in-One Interactive...
GAINESVILLE, Fla. Alafia Ai, Inc. (“ALAFIA”), announces the general availability of AIVAS, an all-in-one interactive high-performance personal supercomputer designed to revolutionize the development...
View ArticleClik here to view.
ヒストソニックス、非侵襲的なヒストトリプシー・プラットフォームの立ち上げ拡大に向けた1億200万ドルのシリーズD資金調達を発表
ミネアポリス （ビジネスワイヤ） — ヒストソニックスは、Edison®ヒストトリプシーシステムのメーカーであり、画期的なヒストトリプシー療法のプラットフォームです。このたびヒストソニックスは、1億200万ドルのシリーズD資金調達を完了したことを発表しました。本ラウンドは、成長段階の投資で世界をリードするアルファ・ウェーブ・ベンチャーズによって主導されており、新規投資家であるAmzak...
View ArticleClik here to view.
HistoSonics宣布获得超额认购的1.02亿美元D轮融资，以推进非侵入性组织摧毁术平台的推出
明尼阿波利斯 (美国商业资讯)– HistoSonics是Edison®组织摧毁术系统和新型组织摧毁术疗法平台的制造商。该公司今天宣布完成超额认购的1.02亿美元D轮融资。本轮融资由全球领先的成长期投资机构Alpha Wave Ventures领投，新投资者Amzak Health和HealthQuest Capital以及现有投资者Johnson & Johnson...
View ArticleClik here to view.
InnoCare Releases 2024 Interim Results and Business Highlights
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2024 interim results and corporate update as...
View ArticleClik here to view.
Propanc Biopharma’s Peer Reviewed Articles for Proenzymes Cancer Treatment...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
ALAFIA、医療分野における人工知能ソフトウェアアプリケーションのためのオールインワンのインタラクティブな高性能パーソナルスーパーコンピュータAIVASを発表
フロリダ州ゲインズビル （ビジネスワイヤ） — Alafia Ai, Inc....
View ArticleClik here to view.
Transforming the Future of Medicine with RNA-Based Therapies
BOSTON Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every...
View ArticleClik here to view.
PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support...
TOKYO PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as “Biomedical Division”) will showcase a prototype of its new cell...
View ArticleClik here to view.
JCR Pharmaceuticals Announces Completion of Clinical Trial Notification...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today the completion of the regulatory review by the Pharmaceuticals and Medical Devices...
View ArticleClik here to view.
PHC、細胞の代謝変化をリアルタイムに可視化するライブセル代謝分析装置「LiCellMoTM（リセルモ）」を発売
東京 （ビジネスワイヤ） — PHC株式会社 バイオメディカ事業部（本社：東京都千代田区、代表取締役社長：中村...
View ArticleClik here to view.
PHC Launches LiCellMoTM Live Cell Metabolic Analyzer for Real-Time...
TOKYO PHC Corporation Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell...
View ArticleClik here to view.
借助RNA疗法改变医学的未来
美国波士顿 (美国商业资讯)– Novotech（诺为泰）是一家专门与生物技术公司合作、加快各个阶段先进新型疗法的开发、可提供全方位服务的国际性临床合同研究组织 (CRO)。现在诺为泰发布了一份新的行业报告，题为《RNA疗法——全球临床试验概况 (2024)》。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View Article